InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-10.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the complete record of transactions filed by Finn Jonathan, Director. Director active across 2 companies, notably Atossa Therapeutics, INC.. Aggregated, 3 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €41k. Activity tracked since 10 April 2024. The latest transaction was filed on 12 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Finn Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
10,000 股0Common StockSEC:0001193125-26-224135:0
25,000 股@ US$1.77100.0% 占其流量Common StockSEC:0000950170-24-043690:0
标准退出：2024年7月9日 (T+90)
1,206 股Class A Common StockSEC:0000899243-23-015559:0
3 条申报中的 3 条
About Finn Jonathan
Jonathan Finn is a Director at Atossa Therapeutics, Inc. As a board member, he participates in the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights into growth and innovation opportunities. He plays a key role in the future direction of the company.
